by PKD Foundation Staff | Jan 15, 2019 | Research, Staff Update
Only a few new drugs for chronic kidney disease (CKD) have been approved in the last several decades because drug companies have shied away from the renal “space.” The need for novel therapies for CKD is compelling, especially because they might mitigate the need for...
by PKD Foundation Staff | Nov 19, 2018 | Research
This year’s American Society of Nephrology (ASN) Kidney Week took place in San Diego, CA, from Oct. 25 to 28. We always look forward to Kidney Week to hear about new developments and initiatives being made in the world of nephrology. Alexis Denny, our Director of...
by PKD Foundation Staff | Nov 16, 2018 | Awareness, Education, Research
#GivingTuesday is right around the corner, and this year, we’re asking: what can you give? Can you give a donation? Our goal for #GivingTuedsay is to raise $18,000 — the amount needed to fund ten weeks of PKD research. When you select the PKD Foundation as your...
by PKD Foundation Staff | May 11, 2018 | Research
This Mother’s Day, we’re celebrating moms and major milestones. We reached out to Jullie Hoggan, who took part in the clinical trials that led to the approval of tolvaptan, to learn more about what having this treatment means to her and her family: The day I became a...
by PKD Foundation Staff | May 9, 2018 | Research
The announcement of our first FDA-approved treatment for ADPKD is not only a major success for PKD patients, but also for nephrologists who have spent decades caring for their health. We reached out recently to Vicente Torres, M.D., Ph.D., of the Mayo Clinic...
by PKD Foundation Staff | May 8, 2018 | Research
Our very own Dr. David Baron shares his personal background with PKD, his journey joining the Foundation and his thoughts on the exciting news about the new treatment for ADPKD: Little did I know when I was studying the effects of vasopressin and its modulators...
